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The carcinogenicity of tobacco smoke condensate for mouse skin, which was
demonstrated by Wynder and his colleagues in 1953 and subsequently (Wynder,
Graham and Cronnger, 1953; and Wynder, 1959 for review), has now been
confirmed by several other groups of workers (Engelbreth-Holm and Ahlmann,
1957; Orris et al., 1958; and Bock and Moore, 1959). Passey (1957) also observed
benign and malignant skin tumours in mice painted with tobacco smoke conden-
sate. He pointed out, however, that the mice, which were of one of the strains
used by Wynder and his colleagues, developed spontaneous ulcers of the skin.
These appeared in untreated and treated mice alike, and the author considered
that their occurrence rendered interpretation of the results difficult. In all these
experiments the smoke condensate was applied at short intervals for long periods.
The possibility that the two stage mechanism of carcinogenesis might be
involved was early considered. Wynder et al. (1953) included an experiment in
which tobacco smoke condensate was applied together with the tumour-promoting
agent, croton oil, to mouse skin. The yield of tumours was no greater than with
smoke condensate alone. Gwynn and Salaman (1956) examined whole smoke con-
densate for the presence of incomplete carcinogens. They tested the condensate
for both tumour-initiating and tumour-promoting activity, and obtained some
evidence of promotion but none of initiation. The results of Hamer and Wood-
house (1956) also suggested that smoke condensate has tumour-promoting action,
but they obtained no evidence for tumour initiation, or for complete carcino-
genicity. Gellhorn (1958), in several large scale experiments, demonstrated very
convincingly the tumour-promoting effect of whole smoke condensate.
Wynder at a meeting at the Chester Beatty Research Institute on July 6,
1959 spoke of evidence which his group had obtained for tumour-promotion by
the nicotine-free basic fraction ofsmoke condensate.
The experiments to be described are a further stage in the examination of
tobacco smoke condensate for incomplete carcinogens (tumour initiators and
promoters). The strong promoting action of one fraction of the condensate is
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MATERIALS AND METHODS
Mice.-Male andfemale mice ofthe" 101 "inbredstrainwere used. Theyhave
been maintained by brother-sister mating in this department since a breeding
pairwas obtained from Dr. T. C, Carter (Radiobiological Research Unit, A.E.R.E.,
Harwell, Didcot, Berks) in November, 1955.
This strain was selected for its high and uniform susceptibility to skin tumour-
induction by initiating and promoting agents (Salaman, 1956). Not until half
way through the experiments was it realized that the mice are not very suitable
for long term experiments because of a high incidence of a renal disease, papillo-
nephritis, first observed in Strain A mice by Gorer (1940), and subsequently
studied in greater detail by Dunn (1944). As in strain A mice, the disease shortens
the life span of affected animals so that few live as long as 18 months.
Mice were fed on cubes according to the Rowett Institute formula (Thomson,
1936) and water ad libitum.
Before the experiment mice were vaccinated on the tail with sheep lymph as
a precaution against ectromelia; all responded with a typical primary response.
The dorsal hair was removed by electric clippers at the beginning ofthe experi-
ment and thereafter as necessary.
Preparation ofcigarette smoke condensate and itsfractions
These were kindly supplied by the Research Laboratories of the Tobacco
Manufacturers' Standing Committee.
Details of the preparations are given by Mr. J. G. Burgan in an appendix to
this paper.
Freshly prepared samples of whole smoke condensate and its neutral fraction
were mailed to us each week, and were used within two weeks of receipt. Storage
between arrival and use was in small sealed ampoules kept protected from light
at 4° C.
Large samples of the smoke phenol fraction were mailed to us at 6-weekly
intervals, and stored similarly before use.
Application ofmaterials to the skin
9,10-Dimethyl-1,2-benzanthracene (DMBA), obtained from L. Light & Co.,
was applied as a 0.15 per cent solution in acetone with a graduated pipette.
All the smoke condensate fractions were too viscous, even after dilution with
acetone, to be applied quantitatively with a graduated pipette, or by a wide-
mouthed dropper: a brushing-on technique was necessary. The whole of the
back from the neck to the root ofthe tail was painted, using a squirrel-hair brush.
EXPLANATION OF PLATE
FIG. 1.-Papillomata on the backofamousetreated oncewith DMBA (300 ,ug.) and then thrice
weekly with the phenolic fraction of cigarette smoke condensate (6-12 mg. per application)
for 27 weeks.
FIG. 2.-Photomicrograph of a nmalignant tumour which arose on the dorsal skin of a mouse
similarly treated with phenolic fraction for 41 weeks after a single application of DMBA.
Invasion of the panniculus carnosus muscle can be seen. (Staining: haemnatoxylin and
eosin. Magnification: x 230.)
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The whole smoke condensate and neutral fractions as received were diluted
3 or 4 times with acetone. After each painting session the average amount of
condensate or fraction applied to each mouse was calculated retrospectively as
follows :-
Average weight of Wt. of fraction + acetone used
per cent fraction in
material applied to- . x fraction-acetone
each mouse No. of mce pated mixture.
With experience it was possible to keep this average to within + 20 per cent
of the intended dose.
The smoke phenol fraction was diluted with acetone 1 in 4, 1 in 6, or 1 in 8
according to dose level. It was found that painting the clipped skin with the
strongest of these concentrations left on the average 12 mg. of smoke phenols on
the mouse; 1 in 6 left 9 mg., and 1 in 8 left 6 mg.
The acetone used was of the Analar grade supplied by British Drug Houses.
Histological examination.-Biopsy specimens, and tissues taken for section
post mortem, were fixed in Zenker's fluid, embedded in paraffin wax, and stained
with haematoxylin and eosin.
EXPERIMENTAL
Experimental I: whole smoke condensate
Thirty male and 32 female mice were clipped, and painted thrice weekly with
whole smoke condensate. At first approximately 25 mg. was applied to each
mouse at each application. This dose was steadily increased during the first
3 weeks up to an average of 40 mg. per mouse, and thereafter maintained at
approximately this level until the 30th week. It was then reduced, because of
toxic effects, to 30 mg. per application.
Table I indicates the progress of the experiment. Fifty-two mice died during
the first 40 weeks: gross pathological changes indicative of papillonephritis
(see p. 624)were present in 13 mice (this incidence does not differ significantly
from that in untreated mice), pneumonic consolidation in 6, intussusception in 3,
enteritis in 3. Nineteen mice died during the 24th week from the toxic effects
of an unusually large dose of smoke condensate applied in error. Several other
mice which showed no obvious lesions, and some of those with only slight kidney
lesions, probably died from the cumulative toxic effects of the condensate.
Advanced post mortem changes prevented satisfactory examination in 11 mice.
One papilloma appeared during the 37th week, when there were only 13
survivors. The same mouse developed a second papilloma during the 44th week,
but died two weeks later. No other tumours have appeared. There are still 3
mice alive after 60 weeks oftreatment but none has any skin tumours.
Experiment II: Neutralfraction
Thirty male and 33 female mice were clipped and painted thrice weekly with
the neutral fraction of tobacco smoke. At first approximately 25 mg. was applied
to each mouse at each application. This dose was steadily increased during the
first 3 weeks up to an average of 40 mg. per mouse. This level was thereafter
maintained.
44
625626 F. J. C. ROE, M. H. SALAMAN AND JUNE COHEN
TABLE I.-Tests of Whole Smoke Condensate and its Neutral Fractionfor




Time applied* mice with Total Total
(in weeks) (g.) Survivors papillomas papillomas carcinomas
Experiment I: Whole Smoke Condensate
0 . - . 62 . . - . -
5 . 0.50 . 62 . - . -
10 . 1.10 . 62 . . -
15 . 1-66 . 59
20 . 2-22 . 50
25 . 2-72 . 30 . . -
30 . 3-17 . 22
35 . 3-52 . 13 . 1 . 1 -
40 . 3-96 . 11 . 2 . 2 . 0
Experiment II: Neutral Fraction
0 . - . 63 . - .
5 . 0.50 . 60 . . -
10 . 1.10 . 59 . - . -
15 . 1-66 . 58 . . - . -
20 . 2-22 . 46
25 . 2-78 . 44 .
30 . 3.38 . 37 . . . -
35 . 3.90 . 25 . 3 . 4 . -
40 . 4.46 . 17 . 1 . 1 . 0
* In both experiments the test material was applied thrice weekly throughout. At first 25 mg.
amounts, diluted 3 or 4 times in acetone, were applied on each occasion. This dose was steadily
increased to 40 mg. per application during the first 3 weeks of treatment. In the case of the neutral
fraction the dose level was maintained at 40 mg. throughout the experiment, but in the case ofwhole
smoke condensate itwasreduced to 30 mg. per application after 30 we3ks becauseof systemictoxicity.
Table I indicates the progress of Experiment II. Thirty-eight mice died
during the first 40 weeks. Compared with the mice treated with whole smoke
condensate, pneumonic consolidation (12 cases) was more frequent in these
mice. Tyzzer's disease caused 3 deaths, intussusception 3, and enteritis a further
4. Papillonephritis was seen in 18 mice. One mouse died as aresult ofhaemorrhage
from a tumour of the tongue. On histological examination this tumour was of
squamous cell type, it showed doubtful invasion of muscle and no metastases.
It was regarded as probably, but not certainly, malignant. Advancedpost mortem
changes prevented satisfactory examination in 10 mice.
Two papillomas appeared during the 32nd week of the experiment, one in
a mouse which died 10 days later (post mortem decay prevented satisfactory
examination), and the other in a mouse which died 4 weeks later and showed
marked renal changes due to papillonephritis. Whilst under observation, both
tumours were notably slow-growing. A third mouse developed a papilloma during
the 40th week of the experiment. Treatment was stopped after 47 weeks. Three
weeks later two of the 10 survivors (both females) developed 2 papillomas each.
These grew more rapidly than those which arose earlier, and soon one of the
tumours on each mouse took on the naked-eye appearances of malignancy. One
was removed at biopsy during the 60th week and was found to be a squamous-
cell carcinoma invading muscle.TUMOUR-.PROMOTION BY CIGARETTE SMOKE FRACTION
Experiment III: Smoke phenolsfraction
One hundred and ten mice, divided into 3 groups, were used in this test.
Each group contained equal numbers of males and females. Groups I and II
consisted of 30 mice each, and Group III of 50 mice. Groups I and III were
given a single application of0.2 ml. 0-15 per cent DMBA in acetone to the clipped
dorsal skin. Group II was not treated at this time. Three weeks later groups
I and II began a course of thrice weekly applications of smoke phenols fraction
in acetone. For the first 9 applications a 25 per cent solution/suspension of the
fraction in acetone (i.e. average of 12 mg. smoke phenolspermouseperapplication)
were given. The skins of many animals became thick and crusted, and 3 mice
died on the 19th day as a result of systemic toxicity. The concentration was
therefore reduced to 12-5 per cent and continued at this level for a further 15
applications. It was then increased to 18.7 per cent for 24 applications, and then
back to 25 per cent from the 49th application (17th week) onwards. Group III
received no treatment apart from the single application ofDMBA.
Ofthe 10 miceofGroup Iwhichdiedduringthe first 40weeksoftheexperiment,
i.e. 37 weeks oftreatmentwithsmokephenolfraction, onehadlymphaticleukaemia
with enlargement of the thymus and lymph glands, one had a large mesenteric
tumour (unfortunately post mortem changes were too advanced for satisfactory
histological examination) 2 showed pneumonic consolidation, and 1 had 2 small
lung adenomas. Four had abscesses in the liver and 3 showed papillonephritis.
Of Group II, 14 mice died. As mentioned above, 3 died early (19th day)
from systemic toxic effects. A large abdominal tumour was seen in a female
mouse which died during the 37th week. This tumour was adherent to the spleen,
pancreas and mesentery. Histological examinationshowedittobe ahaemangioma.
This mouse was one of 3 which had liver abscesses. Three mice showedpneumonic
consolidation, and 7 had papillonephritis.
In Group III 13 mice died and 7 of these were examined post mortem. One
had lymphatic leukaemia with a grossly enlarged thymus and one had 2 small
lung adenomas. One mouse had intussusception, one bronchopneumonia, and
one a large abscess of the neck. Five of the 7 showed kidney lesions indicative
of papillonephritis. Advanced post mortem changes prevented satisfactory
examination of the remaining 6 mice.
Incidence ofskin tumours
Papillomas began to arise in mice of Group I during the 15th week. By the
37th week oftreatment with thephenolic fraction 15 out ofthe 20 survivors ofthis
group bore a total of 65 papillomas (see Table II and Fig. 1). All these tumours
arose on the treated area of skin, and none were seen outside it. At the 37th
week one tumour on a male showed macroscopic features suggestive ofmalignancy.
During the next 4 weeks this tumour grew quickly, ulcerated, and became ad-
herent to deeper structures. It was removed by biopsy during the 41st week of
the experiment, and histological examination showed it to be a poorly differenti-
ated carcinoma which had penetrated the panniculus carnosus muscle (Fig. 2).
Treatment with smoke phenol fraction was stopped after 41 weeks (44th week
of experiment). The mice have been kept under observation; a further probably
malignant tumour has arisen on another mouse (a female) but no specimen has
yet been taken for histological examination.
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TABLE II.-Tests of the Phenolic Fraction of Cigarette Smoke Condensate for
Carcinogenicity, and for Tumour-promotion after a Single Application of
DMBA, on Mouse Skin
Tumour incidence at 40 weeks*
t' ·
Mice
Number with Total Total
of Sur- papil- papil- carci-
Group mice Treatment vivors lomas lomas nomas
I . 30 . 300 ,g. DMBA followed, after 3 . 20 15 65 1
weeks interval, by thrice week-
ly applications of smoke
phenols fractiont
II . 30 . Thrice weekly applications of 16 0 0 0
smoke phenols fraction only
III . 50 300 t,g. DMBA only . 37 4 6t 0
* i.e. After 37 weeks of smoke phenols treatment.
t The smoke phenols fraction was diluted with acetone 1: 4 to 1: 8, depending on dose level (see
text, p. 625). The first 9 applications of smoke phenols fraction were of 12 mg. each; the next 15
were of 6 mg.; the next 24 of 9 mg.; and thereafter all applications were of 12 mg. each.
All outside the treated area (see text, p. 000).
No tumours have appeared on mice of Group II.
Four mice in Group III developed a total of 6 papillomas during the 40 weeks
after treatment with DMBA. All these tumours were situated on the head: no
tumours arose on the treated dorsal skin. It is odd that no such ectopic tumours
arose in Group I mice which received similar treatment with DMBA as well as
treatment with smoke phenols fraction. A similar result was obtained in this
laboratory, in " S " strain mice: treatment with DMBA alone gave rise to many
ectopic tumours, whereas DMBA followed by repeated applications of croton
oil gave rise to very few (Roe, 1956).
Whatever the explanation of this curious phenomenon, the tumour-incidence
in Group I is significantly higher than that in Groups II and III, and the results
clearly indicate that under the experimental conditions described the phenolic
fraction of cigarette smoke condensate has considerable tumour-promoting
activity but no carcinogenic activity.
DISCUSSION
Recent reports (Engelbreth-Holm and Ahlmann, 1957; Orris et al., 1958;
and Bock and Moore, 1959) have confirmed the findings of Wynder and his
colleagues (Wynder, Graham, and Croninger, 1953; and see Wynder, 1959,
for review); and the view is becoming generally accepted that cigarette smoke
condensate is carcinogenic for mouse skin when applied at short intervals for
long periods. The results of Experiments I and II in which the whole smoke
condensate and its neutral fraction were tested in this way were unsatisfactory
because ofpoor survival of mice: a few benign tumours arose in both experiments
after 35 weeks of continuous treatment, and 2 malignant tumours at a much later
date in the neutral fraction experiment.
Much attention has been given to the identification of the carcinogenic com-
ponents in tobacco smoke condensate. Kennaway and Lindsey (1958) give a long
list of individual substances which have been identified in smoke, and a short
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list of 10 for which there is at present evidence of carcinogenicity. Most attention
has been paid to the 3,4-benzpyrene content. Cooper, Lindsey andWaller (1954),
Latarjet et al. (1956), and Bentley and Burgan (1958) all reported amounts of the
order of 1 ,g. of 3,4-benzpyrene in the smoke from 100 g. cigarettes. Wynder
and Wright (1957) and Wynder and Hoffmann (1959) found slightly larger
amounts than this, namely, about 4 jg. per 100 g. cigarettes. Cardon et al. (1956)
on the other hand, estimated the benzpyrene, yield from 100 g. cigarettes at
between 10 and 12 jtg., but the calculations on which these higher estimates
are based have been criticised by Bentley and Burgan (1958). Whichever esti-
mate is correct it is very doubtful whether the amount of benzpyrene in
smoke condensate is sufficient to account for the tumours seen in experiments
with mice. Approximately 4 g. of condensate are produced by smoking 100
cigarettes (of 1 g. each), the amount varying according to the smoking con-
ditions used. If we suppose that the higher figure given by Cardon et al. is
correct, 4 g. of condensate would contain 12 /ug. of 3,4-benzpyrene, and 40
mg. of condensate (the amount applied thrice weekly by Wynder and his
colleagues) would contain approximately 0.1 ,ug. If, on the other hand, the
figures given by Cooper, Lindsey and Waller, Latarjet et al., and Bentley and
Burgan is correct, the amount of 3, 4-benzpyrene per application would be < 0.01
ug. Poel and his colleagues (see Poel, 1959) applied 0.38 /tg. 3,4-benzpyrene to
mice thrice weekly: two carcinomas (after 82 and 83 weeks respectively) and
9 papillomas (after an average of 69 weeks) arose in a group of 55 C57 mice.
The same workers produced 5 papillomas (average induction time - 60 weeks),
but no malignant tumours, in a similar group of mice painted thrice weekly with
0.15 ,g. 3,4-benzpyrene. Even allowing for different experimental techniques and
the strains of mice used, it seems most unlikely that the carcinogenic effect of
smoke condensate observed by Wynder's group, and by others including our-
selves, is due to 3, 4-benzpyrene alone.
Estimates of the amounts of the other carcinogens listed by Kennaway and
Lindsey (1958) are either not available or highly conjectural. But, taking into
account all the available data, and in particular the fact that several of the other
carcinogens present are much weaker than 3,4-benzpyrene, it is unlikely that
their carcinogenic effect combined with that of 3,4-benzpyrene could equal
that of the whole smoke condensate. Dr. Wynder expressed the same view at a
meeting held at the Chester Beatty Research Institute in July 1959. Of course
it may be argued that since several of the substances listed by Kennaway and
Lindsey have not been tested for carcinogenic activity, their possible contribution
cannot be assessed. But to assume that their concentration and potency are
sufficient to add appreciably to the carcinogenic effect of the benzpyrene and the
other known carcinogens is surely inadmissible at this stage.
Turning to the possible role of incomplete carcinogens in tumour production
by cigarette smoke condensate, the fact that a substance is carcinogenic when
applied alone may be taken to indicate that it has both tumour-initiating and
tumour-promoting properties. However, amounts of carcinogenic hydrocarbons
too small to give detectable carcinogenic effect, e.g. 1 /jg. 9-10-dimethyl-1, 2-
benzanthracene (DMBA) (Klein, 1956) have demonstrable initiating action. Total
doses of 3,4-benzpyrene of this order were undoubtedly applied in the course of
the applications ofsmoke condensate by Wynder and others. Thus these amounts
of condensate contained enough 3,4-benzpyrene for the initiation of the tumours
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which arose, though certainly not enough for their production without the aid
of a tumour promoter. Furthermore, in addition to the small amounts of 3,4-
benzpyrene and other complete carcinogens, there may also be present in cigar-
ette smoke condensate incomplete caroinogens of the type of which urethane
and triethylene melamine are examples (Salaman and Roe, 1953; Roe and
Salaman, 1955), i.e. substances with initiating but no promoting action. Little
is known of the distribution of such substances, and their presence in tobacco
smoke condensate has still to be demonstrated.
Thus onquantitativegrounds alone we would expect to find tumour-promoting
substancesin cigarette smoke condensate. Experiment III reported here is a
clear demonstration of tumour-promotion by the phenolic fraction, constituting
about 15-20 per cent of the condensate. Commins and Lindsey (1956) estimated
quantitatively some of the simpler phenols present in cigarette smoke, and
recorded the total yields of 9 different phenolic compounds in micrograms per
cigarette. The yield of phenol itself was 123,tg. per cigarette, quinol-83,ug.,
catechol-61ug., and ortho meta, and para-cresol, together-80 /ug. Resorcinol,
1-naphthol, and 2-naphthol were present in much lower quantities. The total
yield of all 9 compounds amounted to 356ug. per cigarette, which is equivalent
to0.36 g. per 1,000 cigarettes. The yields of phenol and ortho-cresol reported
by Commins and Lindsey were close to those previously recorded by Rayburn,
Harlan and Hanmer (1953).
In the experiments reported here the total yield of phenol fraction from
1,000 cigarettes was4.8 g. (see Appendix). Thus the substances studied by
Commins and Lindsey (1956) account for less than one tenth ofthe phenol fraction
used in Experiment III, and the composition of the remainiug nine tenths is
still not known.
In view of the known tumour-promoting activity of phenol and related com-
pounds, (Boutwell, Rusch and Bosch, 1955; Salaman and Glendenning, 1957;
Boutwell and Bosch, 1959) the result of Experiment III is perhaps not entirely
unexpected. Quantitatively the tumour-promoting effect observed here was
comparable to that for whole smoke condensate observed by Gellhorn (1958),
i.e. the promoting activity of the phenolic fraction could have accounted for
all the effect observed by Gellhorn. However differences in methods and strain
ofmice make such a quantitative comparison unwise.
If we assume that the carcinogenic effect of smoke condensate is due to the
action of initiators (known or unknown) plus promoters (phenols and others),
it is on the face of it difficult to explain why tests of the condensate for initiating
action, by the simultaneous and/or subsequent application of croton oil, gave no
tumours. Certainly promotion was more than adequate. Was enough initiator
applied in these tests? In the experiments of Gwynn and Salaman (1956) a
total of about 1.5g. of smoke condensate was applied as an initiating dose. The
benzpyrene contentofthisaccordingtoCooperetal. (1954) andBentleyandBurgan
(1958) would have been 0.3 pg., and according to Cardon et al. (1956) about
4 pg. This is of the order of the minimum initiating dose of DMBA reported by
Klein (1956). Hamer and Woodhouse applied only about0.2 g. of smoke conden-
sate in their test for tumour-initiation, which would contain an amount of benz-
pyrene definitely below the detectable initiating dose. Thus it is probable that
in the experiments specifically designed to show initiating action, too little
initiator was applied.
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We may sum up the present position with respect to tests on mouse skin by
saying that:
(1) the observed tumour producing action of cigarette smoke conden-
sate is unlikely to be due to contained substances acting as complete
carcinogens,
(2) it can be explained as due to the combined action of tumour initi-
ators and promoters, and,
(3) since its effect can be increased by the addition of initiators but
not of promoters, the relative weakness of the carcinogenic action of
cigarette smoke condensate is due to the paucity of initiators.
There is at present no direct evidence for two-stage carcinogenesis in human
bronchial epithelium. Assuming however that this mechanism operates here,
as it has been shown to do in skin and some other tissues, present evidence sug-
gests that smoking has stronger tumour-promoting than tumour-initiating effect.
Man, whether a smoker or not, is exposed to substances of proved tumour-
initiating power in the polluted atmosphere, and in the products ofsome industrial
processes and in some kinds of food. The correlation between smoking habits
and lung tumour incidence may well be determined not primarily by the carcino-
genic effect of tobacco smoke but by its predominantly tumour-promoting action
on the bronchial epithelium.
SUMMARY
Strong tumour-promoting effect by a phenolic fraction of cigarette smoke
condensate applied after a single tumour-initiating dose of 9,10-dimethyl-1,2-
benzanthracene (DMBA) to the dorsal skin of" 101" strain mice was observed:
sixty-five benign and 2 malignant tumours arose on 30 treated mice during 40
weeks oftreatment. The same dose ofDMBA alone produced a negligible number
of tumours, and thephenolic fraction alone produced none.
"101 "Strain mice treated with whole smoke condensate only, or the neutral
fraction of the condensate only, developed a few papillomas after 35 weeks.
However, the survival of the mice was poor, and very few were alive at the time
when malignant tumours might have been expected: only two were seen.
One of the reasons for the poor survival was a renal disease, papillonephritis,
previously recorded in strain A mice.
Reasons are given for believing that cigarette smoke is richer in tumour-
promoting than in tumour-initiating substances. Phenolic compounds may be
responsible for much ofits promoting activity.
The implications of these findings, and their relevance to the induction of
bronchial carcinoma in man, are briefly discussed.
We wish to express our gratitude to the Tobacco Manufacturers' Standing
Committee for supplying us with tobacco smoke condensate and its fractions.
We also wish to thank all the members of the technical staff of the department
for their assistance. The expenses of the research were partly defrayed out of a
block grant from the British Empire Cancer Campaign.
631632 F. J. C. ROE, M. H. SALAMAN AND JUNE COHEN
APPENDIX: THE PRODUCTION OF CIGARETTE SMOKE CONDENSATE
(byJ. G.Burgan, ResearchLaboratories, TobaccoManufacturers' Standing Committee)
Smoking technique
Cigarettes, a mixture of brands popular in the United Kingdom, are smoked
in batches of 1,000 using an automatic smoking machine of the type described by
Iles and Sharman (1957), arranged to give a puff frequency of 4 per minute, a
puff volume of 15 ml., and a puff duration of 2 seconds. Cigarettes are smoked
to a stub length of 20 mm. The smoke condensate is collected in traps immersed
in a dry ice/acetone mixture, one trap being attached to each smoking position.
The type of cold trap used has been described by Burgan (1959).
Whole smoke condensate
For the production of whole smoke condensate the material collected in the
cold traps is washed out with acetone. The solvent is then removed on the water-
bath and the whole smoke so obtained is stored in the dark in sealed ampoules
at -25° C.
Phenolic and neutralfractions
For the separation of smoke condensate into its main fractions the material
from 1,000 cigarettes, collected in the cold traps, is dissolvedin a mixture (1: 3v/v)
of hydrochloric acid (2N) and ether (peroxide free), the ether used having been
previously treated with sodium wire to remove fluorescent material. The aqueous
acidic layer is separated and the ether layer washed further with portions of
hydrochloric acid (2N, 4 x 100 ml.) to complete the removal of basic compounds.
The ether layer is then washed with portions of saturated sodium bicarbonate
solution (1 x 200 ml., 4 X 100 ml.) to remove carboxylic acids, and with portions
of 3 per cent potassium hydroxide solution (1 x 200 ml., 5 x 100 ml.) to remove
any carboxylic acids remaining together with the phenols present.
The residual ether layer containing the neutral fraction of smoke condensate
is dried over anhydrous magnesium sulphate and the solvent removed on the
water-bath. The neutral fraction obtained is stored in the dark in sealed ampoules
at -25°C.
The phenols are recovered from the combined potassium hydroxide washings.
These are neutralized with hydrochloric acid (2N), excess sodium bicarbonate
(solid) added, and the mixture saturated with sodium chloride and extracted with
portions of ether (1 x 200 ml., 4 x 100 ml.). The combined ether washings,
containing the phenols, are dried over anhydrous magnesium sulphate and the
solvent removed on the water-bath. The phenols obtained are stored in the dark
in sealed ampoules at -25° C.
The average amounts of whole smoke, phenols, and neutral fraction obtained
from 1,000 cigarettes, using the smoking conditions described above, are respec-
tively 29.5 g., 4-8 g. and 16.6 g.
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